The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company codeTOIIW
Company nameOncology Institute Inc
IPO dateMar 13, 2020
Founded at2019
CEODr. Daniel Virnich, M.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address18000 Studebaker Rd
CityCERRITOS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code90703
Phone15627353226
Websitehttps://theoncologyinstitute.com/
Company codeTOIIW
IPO dateMar 13, 2020
Founded at2019
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data